<--- Back to Details
First PageDocument Content
Pharmacology / Fixed dose combination / Organofluorides / Cyclopropanes / Non-nucleoside reverse transcriptase inhibitors / Reverse-transcriptase inhibitor / Antiretroviral drug / Tenofovir / Efavirenz / Chemistry / Organic chemistry / Gilead Sciences
Date: 2014-10-23 17:35:33
Pharmacology
Fixed dose combination
Organofluorides
Cyclopropanes
Non-nucleoside reverse transcriptase inhibitors
Reverse-transcriptase inhibitor
Antiretroviral drug
Tenofovir
Efavirenz
Chemistry
Organic chemistry
Gilead Sciences

Indiana State Department of Health

Add to Reading List

Source URL: www.state.in.us

Download Document from Source Website

File Size: 91,93 KB

Share Document on Facebook

Similar Documents

Gilead Sciences / Chemistry / Fixed dose combination / Pharmacology / Organic chemistry / Bristol-Myers Squibb / Non-nucleoside reverse transcriptase inhibitors / Organofluorides / Tenofovir disoproxil / Efavirenz/emtricitabine/tenofovir / Tenofovir/emtricitabine / Fixed-dose combination

BMS_Gilead_Logo_FINAL.eps

DocID: 1m38a - View Document

Dosage forms / Cyclopropanes / Non-nucleoside reverse transcriptase inhibitors / Lactams / Nevirapine / Pyridines / Reverse-transcriptase inhibitor / Reverse transcriptase / Boehringer Ingelheim / Chemistry / Organic chemistry / Pharmacology

New Zealand Consumer Medicine Information Viramune Tablets and Oral Suspension Nevirapine

DocID: 1gvCL - View Document

Dosage forms / Cyclopropanes / Non-nucleoside reverse transcriptase inhibitors / Pyridines / Lactams / Nevirapine / Boehringer Ingelheim / Reverse-transcriptase inhibitor / Reverse transcriptase / Chemistry / Organic chemistry / Pharmacology

Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine Information

DocID: 1gtrY - View Document

Cyclopropanes / Non-nucleoside reverse transcriptase inhibitors / Antiretroviral drug / Abacavir / Reverse-transcriptase inhibitor / Nevirapine / Efavirenz / Patent / Raltegravir / Chemistry / Organic chemistry / Organofluorides

ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL

DocID: 1fNy0 - View Document

Bristol-Myers Squibb / Cyclopropanes / Pyridines / HIV/AIDS / Nevirapine / Antiretroviral drug / Reverse-transcriptase inhibitor / Efavirenz / Didanosine / Chemistry / Organic chemistry / Non-nucleoside reverse transcriptase inhibitors

1 DECEMBER Correspondence HIV-1 Genotypic DrugResistance Interpretation Algorithms Need to Include HypersusceptibilityAssociated Mutations

DocID: 1fw0V - View Document